Financhill
Back

Windtree Therapeutics Stock Predictions

Windtree Therapeutics Stock Forecast

  • Is Windtree Therapeutics Stock Undervalued?
    The current Windtree Therapeutics [WINT] share price is $0.37. The Score for WINT is 15, which is 70% below its historic median score of 50, and infers higher risk than normal.
  • WINT is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.

Will Windtree Therapeutics Stock Go Up Next Year?

Data Unavailable

Windtree Therapeutics Stock Rating

Data Unavailable

Windtree Therapeutics Stock Price History

Is WINT stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and WINT is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
windtreetx.com

52-Week Data

52-Week High:
14.75
52-Week Low:
0.35

Prediction Charts

Market Cap:
3.33M
Price in USD:
0.37
Volume:
612.11K
Beta:
1.05

Technical Analysis

SMA50:
0.75
SMA100:
3.76
SMA200:
4.38
52-Wk Change:
-97.42%

Stock Predictions

  • Is Windtree Therapeutics stock public?
    Yes, Windtree Therapeutics is a publicly traded company.
  • What is the Windtree Therapeutics stock quote today?
    The Windtree Therapeutics stock price is 0.37 USD today.
  • How to buy Windtree Therapeutics stock online?
    You can buy Windtree Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-20 0.47 0.51 0.52 0.46
Nov-21 0.52 0.51 0.52 0.49
Nov-22 0.50 0.50 0.51 0.49
Nov-25 0.51 0.56 0.56 0.51
Nov-26 0.56 0.56 0.57 0.53
Nov-27 0.55 0.61 0.62 0.54
Nov-29 0.60 0.53 0.60 0.46
Dec-2 0.53 0.54 0.56 0.53
Dec-3 0.54 0.54 0.56 0.51
Dec-4 0.49 0.43 0.51 0.41
Dec-5 0.39 0.39 0.42 0.35
Dec-6 0.39 0.37 0.40 0.36
Dec-9 0.36 0.37 0.38 0.35
Dec-10 0.38 0.37 0.38 0.36

Windtree Therapeutics Earnings

Data Unavailable

Windtree Therapeutics Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $89.20 per share, and an increase next year of $2.80 per share.

* Windtree Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.